JY
IMNM icon

Jeff Yass’s Immunome IMNM Stock Holding History

Jeff Yass’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Sell
32,007
-26,978
-46% -$577K ﹤0.01% 9183
2026
Q1 		$1.29M Sell
58,985
-111,929
-65% -$2.49M ﹤0.01% 7248
2025
Q4 		$3.67M Buy
170,914
+100,749
+144% +$1.77M ﹤0.01% 4539
2025
Q3 		$822K Sell
70,165
-64,997
-48% -$647K ﹤0.01% 7814
2025
Q2 		$1.26M Sell
135,162
-1,241,891
-90% -$10.2M ﹤0.01% 6860
2025
Q1 		$9.27M Buy
1,377,053
+1,294,458
+1,567% +$12.4M ﹤0.01% 2627
2024
Q4 		$877K Buy
82,595
+30,964
+60% +$374K ﹤0.01% 7294
2024
Q3 		$755K Buy
51,631
+21,920
+74% +$311K ﹤0.01% 7474
2024
Q2 		$360K Sell
29,711
-289,803
-91% -$4.53M ﹤0.01% 9058
2024
Q1 		$7.89M Buy
319,514
+284,687
+817% +$5.78M ﹤0.01% 2963
2023
Q4 		$373K Buy
34,827
+9,698
+39% +$80.6K ﹤0.01% 9355
2023
Q3 		$210K Buy
25,129
+7,665
+44% +$56.3K ﹤0.01% 10129
2023
Q2 		$138K Buy
17,464
+4,913
+39% +$26.9K ﹤0.01% 10661
2023
Q1 		$62.6K Sell
12,551
-9,513
-43% -$46.5K ﹤0.01% 11593
2022
Q4 		$48.5K Buy
+22,064
New +$88.9K ﹤0.01% 11414
2022
Q3 		– Sell
-12,052
Closed -$56.5K – 13625
2022
Q2 		$39K Sell
12,052
-21,715
-64% -$79K ﹤0.01% 12105
2022
Q1 		$192K Sell
33,767
-31,682
-48% -$237K ﹤0.01% 11283
2021
Q4 		$848K Buy
65,449
+6,568
+11% +$117K ﹤0.01% 7732
2021
Q3 		$1.43M Buy
+58,881
New +$1.03M ﹤0.01% 6605

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jeff Yass's IMNM Position: Q2 2026 in Review

Jeff Yass reduced its Immunome (IMNM) stake by 46% in Q2 2026, selling an estimated $577K and leaving 32,007 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #9183.

Jeff Yass first reported a position in IMNM in Q3 2021 and has held it in 19 quarters since. The position peaked at $9.27M in Q1 2025. 201 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Jeff Yass held 32,007 shares of Immunome worth $678K as of Q2 2026.
  • Jeff Yass sold 26,978 Immunome shares in Q2 2026, an estimated $577K.
  • Immunome made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9183 holding.
  • Jeff Yass first reported a position in Immunome in Q3 2021 and has held it in 19 quarters since.
  • Jeff Yass's Immunome position peaked at $9.27M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.